Clinical Trial Update: RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for RX-3117 in combination with Abraxane in metastatic pancreatic cancer (Phase 1/Phase 2) with completed status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Rx-3117 (RX-3117)

Snippet

Sponsor: Processa Pharmaceuticals | Conditions: Metastatic Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-12-06